TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity

World J Gastroenterol. 2015 Jul 28;21(28):8615-28. doi: 10.3748/wjg.v21.i28.8615.

Abstract

Aim: To investigate the roles of toll-like receptor 4 (TLR4) and nuclear factor (NF)-κB on cystathionine β synthetase (CBS) expression and visceral hypersensitivity in rats.

Methods: This study used 1-7-wk-old male Sprague-Dawley rats. Western blot analysis was employed to measure the expression of TLR4, NF-κB and the endogenous hydrogen sulfide-producing enzyme CBS in colon dorsal root ganglia (DRG) from control and "irritable bowel syndrome" rats induced by neonatal colonic inflammation (NCI). Colon-specific DRG neurons were labeled with Dil and acutely dissociated to measure excitability with patch-clamp techniques. Immunofluorescence was employed to determine the co-expression of TLR4, NF-κB and CBS in DiI-labeled DRG neurons.

Results: NCI significantly upregulated the expression of TLR4 in colon-related DRGs (0.34 ± 0.12 vs 0.72 ± 0.02 for the control and NCI groups, respectively, P < 0.05). Intrathecal administration of the TLR4-selective inhibitor CLI-095 significantly enhanced the colorectal distention threshold of NCI rats. CLI-095 treatment also markedly reversed the hyperexcitability of colon-specific DRG neurons and reduced the expression of CBS (1.7 ± 0.1 vs 1.1 ± 0.04, P < 0.05) and of the NF-κB subunit p65 (0.8 ± 0.1 vs 0.5 ± 0.1, P < 0.05). Furthermore, the NF-κB-selective inhibitor pyrrolidine dithiocarbamate (PDTC) significantly reduced the upregulation of CBS (1.0 ± 0.1 vs 0.6 ± 0.1, P < 0.05) and attenuated visceral hypersensitivity in the NCI rats. In vitro, incubation of cultured DRG neurons with the TLR4 agonist lipopolysaccharide significantly enhanced the expression of p65 (control vs 8 h: 0.9 ± 0.1 vs 1.3 ± 0.1; control vs 12 h: 0.9 ± 0.1 vs 1.3 ± 0.1, P < 0.05; control vs 24 h: 0.9 ± 0.1 vs 1.6 ± 0.1, P < 0.01) and CBS (control vs 12 h: 1.0 ± 0.1 vs 2.2 ± 0.4; control vs 24 h: 1.0 ± 0.1 vs 2.6 ± 0.1, P < 0.05), whereas the inhibition of p65 via pre-incubation with PDTC significantly reversed the upregulation of CBS expression (1.2 ± 0.1 vs 0.6 ± 0.0, P < 0.01).

Conclusion: Our results suggest that the activation of TLR4 by NCI upregulates CBS expression, which is mediated by the NF-κB signaling pathway, thus contributing to visceral hypersensitivity.

Keywords: Dorsal root ganglion; Hydrogen sulfide; Irritable bowel syndrome; Nuclear factor-kappa B; Toll-like receptors; Visceral hypersensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Colon / innervation*
  • Cystathionine beta-Synthase / metabolism*
  • Disease Models, Animal
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / enzymology*
  • Ganglia, Spinal / physiopathology
  • Hyperalgesia / enzymology*
  • Hyperalgesia / physiopathology
  • Hyperalgesia / prevention & control
  • Irritable Bowel Syndrome / drug therapy
  • Irritable Bowel Syndrome / enzymology*
  • Irritable Bowel Syndrome / physiopathology
  • Lipopolysaccharides / pharmacology
  • Male
  • Neurons / enzymology
  • Pain Perception
  • Pain Threshold
  • Pyrrolidines / pharmacology
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Thiocarbamates / pharmacology
  • Toll-Like Receptor 4 / agonists
  • Toll-Like Receptor 4 / metabolism*
  • Transcription Factor RelA / antagonists & inhibitors
  • Transcription Factor RelA / metabolism*
  • Up-Regulation
  • Visceral Pain / enzymology*
  • Visceral Pain / physiopathology
  • Visceral Pain / prevention & control

Substances

  • Lipopolysaccharides
  • Pyrrolidines
  • Rela protein, rat
  • Thiocarbamates
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • Transcription Factor RelA
  • pyrrolidine dithiocarbamic acid
  • Cystathionine beta-Synthase